American Depositary Shares (“ADS”) Program and Warrant Agent Agreement

Motif Bio plc Announces Voluntary Delisting from the Nasdaq Capital Market

Newron Receives Second Tranche from Financing Agreement with European Investment Bank (EIB)

Expedeon to Present at the Deutsches Eigenkapitalforum in Frankfurt / Main

Vivoryon Therapeutics AG to Publish Third Quarter 2019 Results on November 28, 2019

Motif Bio plc: Directorate Changes

Expedeon AG information on EUR 120 million deal with Abcam on dedicated transaction website

Newron Receives FDA Rare Pediatric Disease Designation for Sarizotan for the Treatment of Rett Syndrome

Rentschler Biopharma Appoints New Executives to Join U.S. Team

CE Mark for avatera®, the First German System for Robot-Assisted, Minimally Invasive Surgery, Setting the Foundation for Strategic Growth Plans